Vildapin Plus Tablet 50 mg+500 mg is a combination oral antidiabetic medication containing Vildagliptin 50 mg and Metformin Hydrochloride 500 mg, formulated to help manage type 2 diabetes mellitus effectively. By combining two complementary mechanisms of action, this formulation provides better glycemic control than either agent alone. It is particularly useful for patients whose blood sugar levels are not adequately controlled with diet, exercise, or monotherapy.
Vildagliptin is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, which enhances the body’s natural incretin system to regulate insulin and glucagon. Metformin is a biguanide that improves insulin sensitivity and reduces hepatic glucose production. Together, they address both postprandial and fasting blood glucose, helping patients achieve target glycemic levels while minimizing the risk of hypoglycemia.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
The combination works synergistically to manage blood glucose through distinct but complementary pathways:
Vildagliptin:
Inhibits DPP-4 enzyme, prolonging incretin hormone action
Increases glucose-dependent insulin secretion
Suppresses glucagon release, lowering liver glucose production
Metformin:
Reduces hepatic gluconeogenesis, lowering fasting blood glucose
Improves peripheral insulin sensitivity
Enhances glucose uptake in muscles and reduces intestinal glucose absorption
By targeting multiple aspects of glucose metabolism, Vildapin Plus provides stable and effective glycemic control for adults with type 2 diabetes.
Vildapin Plus Tablet 50 mg+500 mg is indicated for:
Type 2 diabetes mellitus when diet and exercise alone are insufficient
Patients requiring combination therapy to achieve glycemic targets
Management of both fasting and postprandial blood glucose levels
Use as first-line combination therapy in patients inadequately controlled by monotherapy with either Vildagliptin or Metformin
It is suitable for adult patients seeking effective and well-tolerated glycemic control.
The usual recommended dose is one tablet twice daily, or as prescribed by a physician.
Tablets should be taken with meals to reduce gastrointestinal side effects.
Swallow the tablet whole with water; do not crush or chew.
Blood glucose levels should be regularly monitored to adjust dosage as needed.
Dosage adjustments may be required for patients with renal or hepatic impairment. Consistent adherence to prescribed therapy, diet, and exercise is crucial for optimal results.
Use under medical supervision, especially in patients with kidney, liver, or heart conditions.
Inform your doctor of all other medications, as both components can interact with certain drugs.
Not suitable for type 1 diabetes or diabetic ketoacidosis.
Pregnancy or breastfeeding patients should consult a healthcare professional before use.
Avoid excessive alcohol consumption, as it may increase the risk of lactic acidosis with Metformin.
Common side effects may include:
Gastrointestinal discomfort, including nausea, diarrhea, or bloating
Headache or dizziness
Mild hypoglycemia, especially when combined with other antidiabetic agents
Nasopharyngitis or mild cold-like symptoms
Serious adverse effects, though rare, may include lactic acidosis, severe hypoglycemia, or liver enzyme elevation. Seek immediate medical attention if severe symptoms occur.
Store Vildapin Plus Tablet 50 mg+500 mg in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Vildapin Plus Tablet 50 mg+500 mg offers a safe and effective dual approach for managing type 2 diabetes, providing superior glycemic control, improving insulin response, and reducing the risk of complications under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet